Nova Leap Health Corp. Closes Private Placement

Press Release - July 6, 2017 (178 downloads)

HALIFAX, NOVA SCOTIA – July 6, 2017 – NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or the “Company”) has closed its previously announced non-brokered private placement by raising $1,052,500 through the issuance of 5,262,500 Units at a price of $0.20 per unit.   Each unit is comprised of one common share of the Company and a one-half common share purchase warrant.  Two half warrants entitle the holder to acquire one common share of the Company for $0.35 for a period of 24 months from the closing date.  All securities issued pursuant to this private placement are subject to a 4 month hold period that expires on November 7, 2017.

 

Certain officers, directors and Insiders of the Company subscribed for an aggregate of 2,250,000 units.

 

The proceeds from the private placement will be used for general working capital purposes. The private placement remains subject to final acceptance by the TSX Venture Exchange.

 

For further information:

Christopher Dobbin, Director, President and CEO Nova Leap Health Corp., T: 902 401 9480   F:  902 482 5177 cdobbin@novaleaphealth.com

John Boidman, Vice President Renmark Financial Communications Inc. T: 416 644-2020 or 514 939-3989 jboidman@renmarkfinancial.com

 

CAUTIONARY STATEMENT:

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

(Not for distribution to US wire services or for dissemination in the United States of America)

EMAIL NEWSLETTER

ADDRESS

7071 Bayers Road, Suite 5003
Halifax, Nova Scotia Canada B3L 2C2

CONTACT

902.401.9480
cdobbin@novaleaphealth.com

QUESTIONS/COMMENTS